BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27859539)

  • 1. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.
    Borrego-Écija S; Morgado J; Palencia-Madrid L; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Balasa M; Antonell A; Molinuevo JL; Lladó A; Martínez de Pancorbo M; Gelpi E; Sánchez-Valle R
    Dement Geriatr Cogn Disord; 2017; 44(3-4):213-221. PubMed ID: 28934750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
    Tacik P; DeTure MA; Carlomagno Y; Lin WL; Murray ME; Baker MC; Josephs KA; Boeve BF; Wszolek ZK; Graff-Radford NR; Parisi JE; Petrucelli L; Rademakers R; Isaacson RS; Heilman KM; Petersen RC; Dickson DW; Kouri N
    Brain Pathol; 2017 Sep; 27(5):612-626. PubMed ID: 27529406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tau mutation, p.K317N, causes globular glial tauopathy.
    Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.
    Erro ME; Zelaya MV; Mendioroz M; Larumbe R; Ortega-Cubero S; Lanciego JL; Lladó A; Cabada T; Tuñón T; García-Bragado F; Luquin MR; Pastor P; Ferrer I
    J Neurol; 2019 Oct; 266(10):2396-2405. PubMed ID: 31190169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia.
    Forrest SL; Shepherd CE; McCann H; Kwok JB; Halliday GM; Kril JJ
    Acta Neuropathol; 2021 May; 141(5):791-794. PubMed ID: 33744978
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
    Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
    Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
    Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
    Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of familial tauopathy.
    Tsuboi Y
    Neuropathology; 2006 Oct; 26(5):471-4. PubMed ID: 17080727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Globular Glial Tauopathies and Frontotemporal Dementia-Expanding the Spectrum of Gliocentric Disorders: A Review.
    Forrest SL; Kril JJ; Kovacs GG
    JAMA Neurol; 2021 Aug; 78(8):1004-1014. PubMed ID: 34152367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical globular glial tauopathy with a combination of types I and II pathology.
    Kon T; Mori F; Arai A; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Wakabayashi K
    Neuropathology; 2019 Apr; 39(2):127-134. PubMed ID: 30723950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
    García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau pathology in a family with dementia and a P301L mutation in tau.
    Mirra SS; Murrell JR; Gearing M; Spillantini MG; Goedert M; Crowther RA; Levey AI; Jones R; Green J; Shoffner JM; Wainer BH; Schmidt ML; Trojanowski JQ; Ghetti B
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):335-45. PubMed ID: 10218629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Gossye H; Van Mossevelde S; Sieben A; Bjerke M; Hendrickx Van de Craen E; van der Zee J; De Deyn PP; De Bleecker J; Versijpt J; van den Ende J; Deryck O; Bourgeois P; Bier JC; Goethals M; Vandenberghe R; Engelborghs S; Van Broeckhoven C
    Brain; 2023 Apr; 146(4):1624-1636. PubMed ID: 36171642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, radiologic, and pathologic features of the globular glial tauopathy subtype of frontotemporal lobar degeneration in right temporal variant frontotemporal dementia with salient features of Geschwind syndrome.
    Josephy-Hernandez S; Brickhouse M; Champion S; Kim DD; Touroutoglou A; Frosch M; Dickerson BC
    Neurocase; 2022 Aug; 28(4):375-381. PubMed ID: 36251576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.